Matthew Keller
Concepts (499)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 55 | 2026 | 2228 | 4.500 |
Why?
| | Genome-Wide Association Study | 44 | 2025 | 1526 | 4.490 |
Why?
| | Biological Specimen Banks | 7 | 2025 | 137 | 3.810 |
Why?
| | Models, Genetic | 23 | 2025 | 537 | 3.000 |
Why?
| | Multifactorial Inheritance | 17 | 2025 | 242 | 2.910 |
Why?
| | Schizophrenia | 16 | 2022 | 476 | 2.840 |
Why?
| | Genetic Predisposition to Disease | 35 | 2025 | 2455 | 2.690 |
Why?
| | Gene-Environment Interaction | 9 | 2021 | 188 | 1.840 |
Why?
| | Dermatology | 5 | 2025 | 131 | 1.810 |
Why?
| | Homozygote | 11 | 2023 | 196 | 1.730 |
Why?
| | Genome, Human | 13 | 2021 | 425 | 1.650 |
Why?
| | Genetics, Population | 5 | 2022 | 225 | 1.600 |
Why?
| | Phenotype | 32 | 2025 | 3186 | 1.570 |
Why?
| | Genetic Variation | 19 | 2022 | 992 | 1.490 |
Why?
| | Paternal Inheritance | 2 | 2021 | 3 | 1.320 |
Why?
| | Maternal Inheritance | 2 | 2021 | 15 | 1.310 |
Why?
| | Statistics as Topic | 3 | 2021 | 277 | 1.310 |
Why?
| | Consanguinity | 4 | 2018 | 50 | 1.170 |
Why?
| | Genomics | 10 | 2026 | 851 | 1.150 |
Why?
| | Quantitative Trait, Heritable | 8 | 2025 | 118 | 1.090 |
Why?
| | United Kingdom | 9 | 2025 | 376 | 1.090 |
Why?
| | Twins | 5 | 2021 | 156 | 1.090 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 771 | 1.080 |
Why?
| | Mental Disorders | 12 | 2022 | 1133 | 1.060 |
Why?
| | Humans | 150 | 2026 | 145625 | 1.050 |
Why?
| | Family | 7 | 2024 | 680 | 1.050 |
Why?
| | Twins, Dizygotic | 6 | 2013 | 108 | 1.040 |
Why?
| | Linkage Disequilibrium | 7 | 2026 | 257 | 1.010 |
Why?
| | Family Characteristics | 2 | 2025 | 202 | 1.000 |
Why?
| | Marriage | 3 | 2025 | 122 | 0.970 |
Why?
| | Genome | 3 | 2018 | 307 | 0.970 |
Why?
| | Twins, Monozygotic | 5 | 2013 | 132 | 0.950 |
Why?
| | Academic Success | 2 | 2023 | 31 | 0.950 |
Why?
| | Cognition | 15 | 2022 | 1286 | 0.920 |
Why?
| | Chromosomes | 1 | 2026 | 105 | 0.910 |
Why?
| | Reproduction | 4 | 2022 | 208 | 0.900 |
Why?
| | Smoking | 7 | 2025 | 1478 | 0.890 |
Why?
| | Software | 3 | 2017 | 673 | 0.870 |
Why?
| | Family Health | 2 | 2024 | 192 | 0.860 |
Why?
| | Haplotypes | 5 | 2026 | 505 | 0.850 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 154 | 0.840 |
Why?
| | Environment | 5 | 2017 | 295 | 0.840 |
Why?
| | Spouses | 1 | 2025 | 105 | 0.810 |
Why?
| | Informed Consent | 2 | 2016 | 194 | 0.790 |
Why?
| | Communication Barriers | 2 | 2016 | 129 | 0.790 |
Why?
| | Sexual Partners | 1 | 2025 | 195 | 0.790 |
Why?
| | Genotype | 13 | 2021 | 1866 | 0.780 |
Why?
| | Depression | 4 | 2022 | 1566 | 0.780 |
Why?
| | Genetics, Behavioral | 2 | 2020 | 17 | 0.780 |
Why?
| | Body Height | 6 | 2025 | 202 | 0.740 |
Why?
| | Biological Evolution | 4 | 2018 | 471 | 0.740 |
Why?
| | Algorithms | 4 | 2026 | 1843 | 0.740 |
Why?
| | Mentors | 2 | 2025 | 215 | 0.720 |
Why?
| | Intelligence | 6 | 2025 | 118 | 0.710 |
Why?
| | Tobacco Use Disorder | 3 | 2025 | 217 | 0.690 |
Why?
| | Female | 79 | 2026 | 79080 | 0.690 |
Why?
| | Pedigree | 5 | 2024 | 507 | 0.660 |
Why?
| | Educational Status | 8 | 2024 | 466 | 0.650 |
Why?
| | Computer Simulation | 7 | 2022 | 1014 | 0.650 |
Why?
| | Male | 67 | 2026 | 73014 | 0.640 |
Why?
| | Inbreeding Depression | 2 | 2021 | 3 | 0.630 |
Why?
| | Research Design | 6 | 2018 | 1139 | 0.600 |
Why?
| | Twin Studies as Topic | 3 | 2018 | 14 | 0.590 |
Why?
| | Adult | 51 | 2026 | 40821 | 0.590 |
Why?
| | Alleles | 10 | 2024 | 900 | 0.590 |
Why?
| | Bias | 5 | 2022 | 196 | 0.590 |
Why?
| | Wearable Electronic Devices | 3 | 2025 | 75 | 0.590 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 662 | 0.560 |
Why?
| | Cervical Length Measurement | 1 | 2018 | 5 | 0.550 |
Why?
| | Alcoholism | 6 | 2025 | 830 | 0.550 |
Why?
| | Hyperhidrosis | 1 | 2018 | 6 | 0.540 |
Why?
| | Fees and Charges | 1 | 2018 | 12 | 0.540 |
Why?
| | Psychological Trauma | 1 | 2019 | 58 | 0.540 |
Why?
| | Tympanoplasty | 1 | 2017 | 8 | 0.520 |
Why?
| | Tympanic Membrane Perforation | 1 | 2017 | 15 | 0.510 |
Why?
| | Botulinum Toxins | 1 | 2018 | 49 | 0.510 |
Why?
| | Auditory Threshold | 1 | 2017 | 47 | 0.510 |
Why?
| | Socioeconomic Factors | 3 | 2019 | 1323 | 0.500 |
Why?
| | Beauty | 2 | 2013 | 19 | 0.500 |
Why?
| | Blast Injuries | 1 | 2017 | 62 | 0.490 |
Why?
| | Drug Eruptions | 1 | 2016 | 28 | 0.490 |
Why?
| | Third-Party Consent | 1 | 2016 | 21 | 0.480 |
Why?
| | Erlotinib Hydrochloride | 1 | 2016 | 71 | 0.480 |
Why?
| | Proxy | 1 | 2016 | 37 | 0.480 |
Why?
| | Skin Neoplasms | 2 | 2014 | 805 | 0.480 |
Why?
| | Psychotic Disorders | 2 | 2016 | 181 | 0.470 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 567 | 0.460 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 880 | 0.450 |
Why?
| | Genetic Loci | 9 | 2022 | 272 | 0.450 |
Why?
| | Chromosome Mapping | 4 | 2026 | 505 | 0.450 |
Why?
| | Creativity | 1 | 2015 | 19 | 0.440 |
Why?
| | Internship and Residency | 2 | 2025 | 1269 | 0.440 |
Why?
| | Nootropic Agents | 3 | 2021 | 30 | 0.440 |
Why?
| | Physician-Patient Relations | 3 | 2016 | 595 | 0.430 |
Why?
| | Body Mass Index | 5 | 2024 | 2446 | 0.420 |
Why?
| | Likelihood Functions | 5 | 2022 | 138 | 0.410 |
Why?
| | Parkinson Disease | 3 | 2025 | 614 | 0.410 |
Why?
| | Quantitative Trait Loci | 4 | 2024 | 388 | 0.400 |
Why?
| | Genealogy and Heraldry | 1 | 2013 | 3 | 0.400 |
Why?
| | Nevus, Pigmented | 1 | 2014 | 35 | 0.400 |
Why?
| | Middle Aged | 34 | 2026 | 36359 | 0.390 |
Why?
| | Deglutition Disorders | 2 | 2025 | 159 | 0.390 |
Why?
| | Depressive Disorder | 2 | 2007 | 359 | 0.390 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 132 | 0.390 |
Why?
| | Genetic Pleiotropy | 1 | 2013 | 36 | 0.380 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 175 | 0.380 |
Why?
| | Bipolar Disorder | 2 | 2015 | 281 | 0.380 |
Why?
| | Telemedicine | 1 | 2022 | 956 | 0.370 |
Why?
| | Medication Therapy Management | 1 | 2013 | 73 | 0.370 |
Why?
| | Fluorouracil | 1 | 2013 | 231 | 0.370 |
Why?
| | Affect | 2 | 2005 | 317 | 0.360 |
Why?
| | Dementia | 1 | 2016 | 322 | 0.350 |
Why?
| | Genes, Recessive | 1 | 2012 | 77 | 0.350 |
Why?
| | Marijuana Abuse | 1 | 2015 | 215 | 0.350 |
Why?
| | Inbreeding | 1 | 2011 | 20 | 0.340 |
Why?
| | Gene Frequency | 6 | 2022 | 495 | 0.340 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 319 | 0.330 |
Why?
| | Sex Characteristics | 2 | 2013 | 798 | 0.330 |
Why?
| | Young Adult | 20 | 2026 | 14240 | 0.320 |
Why?
| | Social Environment | 4 | 2019 | 246 | 0.320 |
Why?
| | Genetic Markers | 3 | 2020 | 337 | 0.310 |
Why?
| | Risk Factors | 14 | 2025 | 10840 | 0.310 |
Why?
| | Adaptation, Psychological | 3 | 2022 | 718 | 0.310 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 104 | 0.310 |
Why?
| | Substance-Related Disorders | 5 | 2025 | 1098 | 0.310 |
Why?
| | Bariatric Surgery | 2 | 2024 | 248 | 0.310 |
Why?
| | Live Birth | 2 | 2020 | 81 | 0.300 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2009 | 27 | 0.300 |
Why?
| | Uniparental Disomy | 1 | 2009 | 9 | 0.300 |
Why?
| | Aged | 18 | 2026 | 26251 | 0.300 |
Why?
| | Models, Statistical | 5 | 2018 | 667 | 0.300 |
Why?
| | Negative-Pressure Wound Therapy | 2 | 2020 | 29 | 0.290 |
Why?
| | Life Change Events | 2 | 2007 | 144 | 0.290 |
Why?
| | Fathers | 1 | 2009 | 53 | 0.290 |
Why?
| | Models, Theoretical | 3 | 2021 | 558 | 0.280 |
Why?
| | Stillbirth | 2 | 2019 | 83 | 0.280 |
Why?
| | Personality | 2 | 2012 | 132 | 0.280 |
Why?
| | Dysphonia | 2 | 2018 | 13 | 0.280 |
Why?
| | Psychiatry | 1 | 2011 | 182 | 0.280 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2025 | 221 | 0.280 |
Why?
| | Retrospective Studies | 18 | 2026 | 17291 | 0.280 |
Why?
| | Evolution, Molecular | 2 | 2017 | 501 | 0.270 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 627 | 0.270 |
Why?
| | Laryngeal Diseases | 2 | 2018 | 31 | 0.270 |
Why?
| | Registries | 2 | 2015 | 2382 | 0.270 |
Why?
| | Adolescent | 27 | 2026 | 22451 | 0.270 |
Why?
| | Psoriasis | 2 | 2021 | 110 | 0.270 |
Why?
| | Mendelian Randomization Analysis | 3 | 2024 | 68 | 0.270 |
Why?
| | Genetic Association Studies | 4 | 2019 | 376 | 0.270 |
Why?
| | Inheritance Patterns | 4 | 2021 | 47 | 0.260 |
Why?
| | Parent-Child Relations | 2 | 2021 | 266 | 0.260 |
Why?
| | Inappropriate Prescribing | 2 | 2026 | 66 | 0.260 |
Why?
| | Myeloproliferative Disorders | 2 | 2019 | 21 | 0.260 |
Why?
| | Chromosomes, Human | 3 | 2018 | 45 | 0.260 |
Why?
| | Computational Biology | 1 | 2011 | 675 | 0.240 |
Why?
| | Pediatric Obesity | 2 | 2024 | 635 | 0.230 |
Why?
| | Facial Injuries | 1 | 2026 | 25 | 0.230 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3396 | 0.230 |
Why?
| | Practice Patterns, Physicians' | 2 | 2021 | 1370 | 0.230 |
Why?
| | Pregnancy | 7 | 2025 | 7217 | 0.230 |
Why?
| | Selection, Genetic | 2 | 2012 | 269 | 0.220 |
Why?
| | Weather | 1 | 2005 | 43 | 0.220 |
Why?
| | Neurodevelopmental Disorders | 2 | 2019 | 234 | 0.220 |
Why?
| | Surveys and Questionnaires | 6 | 2025 | 6050 | 0.220 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2218 | 0.220 |
Why?
| | Positive-Pressure Respiration | 1 | 2026 | 115 | 0.220 |
Why?
| | Biofeedback, Psychology | 1 | 2025 | 35 | 0.220 |
Why?
| | Executive Function | 2 | 2022 | 461 | 0.210 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2025 | 64 | 0.210 |
Why?
| | Noninvasive Ventilation | 1 | 2026 | 66 | 0.210 |
Why?
| | Needs Assessment | 2 | 2020 | 403 | 0.210 |
Why?
| | Recombination, Genetic | 2 | 2016 | 202 | 0.200 |
Why?
| | Apolipoproteins E | 1 | 2024 | 97 | 0.200 |
Why?
| | Pregnancy Complications | 2 | 2019 | 605 | 0.200 |
Why?
| | Alcohol Drinking | 2 | 2022 | 847 | 0.200 |
Why?
| | Cognition Disorders | 2 | 2019 | 547 | 0.190 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 11 | 0.190 |
Why?
| | Ureteral Calculi | 1 | 2022 | 15 | 0.190 |
Why?
| | Tobacco Products | 1 | 2024 | 90 | 0.190 |
Why?
| | Parents | 2 | 2022 | 1393 | 0.180 |
Why?
| | Population Health | 1 | 2023 | 44 | 0.180 |
Why?
| | Lithotripsy | 1 | 2022 | 47 | 0.180 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2022 | 46 | 0.180 |
Why?
| | Birth Weight | 1 | 2025 | 521 | 0.180 |
Why?
| | Face | 2 | 2013 | 177 | 0.180 |
Why?
| | Receptors, Nicotinic | 2 | 2025 | 327 | 0.180 |
Why?
| | Internationality | 1 | 2022 | 156 | 0.180 |
Why?
| | Fractures, Open | 1 | 2022 | 28 | 0.180 |
Why?
| | Faculty, Medical | 1 | 2025 | 305 | 0.180 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 421 | 0.170 |
Why?
| | Tobacco Use | 1 | 2022 | 67 | 0.170 |
Why?
| | Health Care Costs | 2 | 2022 | 418 | 0.170 |
Why?
| | Mutation, Missense | 2 | 2019 | 331 | 0.170 |
Why?
| | Compartment Syndromes | 1 | 2022 | 36 | 0.170 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 15 | 0.170 |
Why?
| | Respiratory Rate | 1 | 2021 | 24 | 0.170 |
Why?
| | Tibial Fractures | 1 | 2022 | 75 | 0.170 |
Why?
| | Wireless Technology | 1 | 2021 | 18 | 0.170 |
Why?
| | Gastric Bypass | 1 | 2022 | 115 | 0.170 |
Why?
| | Tremor | 2 | 2018 | 98 | 0.160 |
Why?
| | Genotyping Techniques | 2 | 2018 | 72 | 0.160 |
Why?
| | Respiratory Sounds | 1 | 2021 | 102 | 0.160 |
Why?
| | Pregnancy, Twin | 1 | 2020 | 19 | 0.160 |
Why?
| | Inpatients | 2 | 2022 | 538 | 0.160 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 47 | 0.160 |
Why?
| | Cohort Studies | 7 | 2026 | 6045 | 0.160 |
Why?
| | Aged, 80 and over | 7 | 2026 | 8351 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2025 | 385 | 0.150 |
Why?
| | Hysterectomy | 1 | 2021 | 138 | 0.150 |
Why?
| | Analgesics, Opioid | 2 | 2026 | 1158 | 0.150 |
Why?
| | Mental Health | 2 | 2024 | 771 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2020 | 89 | 0.150 |
Why?
| | Hospitalization | 5 | 2021 | 2468 | 0.150 |
Why?
| | Medicaid | 2 | 2021 | 472 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 50 | 0.150 |
Why?
| | Friends | 1 | 2019 | 57 | 0.150 |
Why?
| | History, 21st Century | 1 | 2020 | 224 | 0.150 |
Why?
| | Exotoxins | 1 | 2019 | 16 | 0.150 |
Why?
| | Florida | 4 | 2019 | 117 | 0.150 |
Why?
| | Duffy Blood-Group System | 1 | 2019 | 6 | 0.150 |
Why?
| | Dermatitis, Atopic | 1 | 2022 | 319 | 0.140 |
Why?
| | Janus Kinase 2 | 1 | 2019 | 31 | 0.140 |
Why?
| | Siblings | 2 | 2013 | 196 | 0.140 |
Why?
| | Orbital Cellulitis | 1 | 2019 | 17 | 0.140 |
Why?
| | Cone Opsins | 1 | 2018 | 2 | 0.140 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 36 | 0.140 |
Why?
| | Hemolysin Proteins | 1 | 2019 | 36 | 0.140 |
Why?
| | Laryngismus | 1 | 2018 | 10 | 0.140 |
Why?
| | History, 20th Century | 1 | 2020 | 330 | 0.140 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2018 | 20 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2022 | 284 | 0.140 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 207 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2019 | 109 | 0.140 |
Why?
| | Antimicrobial Stewardship | 1 | 2021 | 136 | 0.140 |
Why?
| | Chronic Pain | 1 | 2023 | 302 | 0.140 |
Why?
| | Lasers | 1 | 2018 | 127 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1125 | 0.130 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2019 | 91 | 0.130 |
Why?
| | Laparoscopy | 1 | 2022 | 474 | 0.130 |
Why?
| | Pregnancy Trimester, Second | 1 | 2018 | 91 | 0.130 |
Why?
| | Europe | 2 | 2022 | 420 | 0.130 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2910 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2020 | 257 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5397 | 0.130 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2020 | 187 | 0.130 |
Why?
| | Audiometry, Pure-Tone | 1 | 2017 | 25 | 0.130 |
Why?
| | Opioid-Related Disorders | 1 | 2026 | 611 | 0.130 |
Why?
| | Neuromuscular Agents | 1 | 2018 | 46 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2022 | 387 | 0.130 |
Why?
| | Mouth | 1 | 2017 | 84 | 0.130 |
Why?
| | Botulinum Toxins, Type A | 1 | 2018 | 60 | 0.130 |
Why?
| | Heart Rate | 1 | 2021 | 844 | 0.130 |
Why?
| | Databases, Factual | 4 | 2025 | 1481 | 0.130 |
Why?
| | Synaptic Transmission | 1 | 2019 | 292 | 0.130 |
Why?
| | Event-Related Potentials, P300 | 1 | 2016 | 17 | 0.120 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 306 | 0.120 |
Why?
| | Endophenotypes | 1 | 2016 | 24 | 0.120 |
Why?
| | Neurocognitive Disorders | 1 | 2017 | 33 | 0.120 |
Why?
| | Phylogeny | 1 | 2021 | 921 | 0.120 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 566 | 0.120 |
Why?
| | Parenting | 1 | 2020 | 309 | 0.120 |
Why?
| | Case-Control Studies | 4 | 2017 | 3633 | 0.120 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 169 | 0.120 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 371 | 0.120 |
Why?
| | Patient Readmission | 1 | 2022 | 771 | 0.120 |
Why?
| | Patient Discharge | 2 | 2022 | 991 | 0.120 |
Why?
| | United States | 8 | 2026 | 16041 | 0.120 |
Why?
| | Postpartum Period | 1 | 2019 | 377 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 634 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 611 | 0.120 |
Why?
| | Regression Analysis | 3 | 2021 | 994 | 0.120 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 147 | 0.120 |
Why?
| | Retina | 1 | 2018 | 330 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 443 | 0.110 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 189 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2022 | 878 | 0.110 |
Why?
| | Telephone | 1 | 2016 | 175 | 0.110 |
Why?
| | Pityriasis Rubra Pilaris | 1 | 2015 | 1 | 0.110 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2020 | 383 | 0.110 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 22 | 0.110 |
Why?
| | Guanylate Cyclase | 1 | 2015 | 36 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 627 | 0.110 |
Why?
| | Curriculum | 1 | 2022 | 1074 | 0.110 |
Why?
| | Genetic Research | 1 | 2015 | 17 | 0.110 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1992 | 0.110 |
Why?
| | Comprehension | 1 | 2016 | 175 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2015 | 130 | 0.110 |
Why?
| | Staphylococcus aureus | 1 | 2019 | 458 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2019 | 486 | 0.100 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 396 | 0.100 |
Why?
| | Principal Component Analysis | 1 | 2015 | 192 | 0.100 |
Why?
| | Comorbidity | 2 | 2019 | 1652 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2024 | 1130 | 0.100 |
Why?
| | Masculinity | 1 | 2013 | 10 | 0.100 |
Why?
| | Asthma | 1 | 2026 | 1800 | 0.100 |
Why?
| | Antisocial Personality Disorder | 1 | 2015 | 123 | 0.100 |
Why?
| | Genetic Fitness | 1 | 2014 | 60 | 0.100 |
Why?
| | Genetic Testing | 1 | 2017 | 491 | 0.100 |
Why?
| | Moral Obligations | 1 | 2013 | 15 | 0.100 |
Why?
| | Prescription Drug Diversion | 1 | 2013 | 13 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2022 | 1169 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6449 | 0.100 |
Why?
| | Biopsy, Needle | 1 | 2014 | 182 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2015 | 146 | 0.100 |
Why?
| | Interpersonal Relations | 2 | 2008 | 387 | 0.100 |
Why?
| | Administration, Topical | 1 | 2013 | 153 | 0.100 |
Why?
| | Liability, Legal | 1 | 2013 | 42 | 0.100 |
Why?
| | Africa | 1 | 2013 | 119 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 314 | 0.100 |
Why?
| | Biopsy | 1 | 2016 | 1073 | 0.090 |
Why?
| | Child | 10 | 2026 | 22638 | 0.090 |
Why?
| | Outpatients | 1 | 2016 | 437 | 0.090 |
Why?
| | Anxiety Disorders | 1 | 2016 | 351 | 0.090 |
Why?
| | Adolescent Development | 1 | 2013 | 72 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2019 | 876 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 982 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2411 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2019 | 976 | 0.090 |
Why?
| | Choice Behavior | 1 | 2013 | 179 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2022 | 11744 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 1 | 2015 | 432 | 0.090 |
Why?
| | Monitoring, Physiologic | 2 | 2025 | 278 | 0.090 |
Why?
| | Parathyroid Glands | 1 | 2011 | 11 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 646 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 629 | 0.080 |
Why?
| | Virginia | 2 | 2009 | 57 | 0.080 |
Why?
| | Population Density | 1 | 2011 | 90 | 0.080 |
Why?
| | NF-kappa B | 1 | 2015 | 674 | 0.080 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2011 | 70 | 0.080 |
Why?
| | Life Style | 2 | 2021 | 495 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 165 | 0.080 |
Why?
| | Microbiota | 1 | 2017 | 724 | 0.080 |
Why?
| | Anthropometry | 2 | 2024 | 203 | 0.070 |
Why?
| | Military Personnel | 1 | 2017 | 715 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2013 | 489 | 0.070 |
Why?
| | Decision Making | 1 | 2016 | 987 | 0.070 |
Why?
| | International Classification of Diseases | 2 | 2019 | 142 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 481 | 0.070 |
Why?
| | Risk | 3 | 2019 | 917 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 3005 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2016 | 889 | 0.070 |
Why?
| | Child, Preschool | 5 | 2026 | 11888 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2009 | 239 | 0.070 |
Why?
| | Prevalence | 1 | 2015 | 2852 | 0.060 |
Why?
| | Thinking | 1 | 2008 | 68 | 0.060 |
Why?
| | Personality Inventory | 1 | 2007 | 132 | 0.060 |
Why?
| | Health Status | 2 | 2024 | 822 | 0.060 |
Why?
| | Diseases in Twins | 1 | 2007 | 114 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2018 | 1293 | 0.060 |
Why?
| | Incidence | 2 | 2025 | 2910 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2011 | 774 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1184 | 0.060 |
Why?
| | Gestational Age | 2 | 2019 | 989 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1318 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2006 | 64 | 0.060 |
Why?
| | Personality Assessment | 1 | 2005 | 75 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2591 | 0.060 |
Why?
| | Length of Stay | 2 | 2022 | 1342 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 512 | 0.060 |
Why?
| | Deglutition | 1 | 2025 | 73 | 0.060 |
Why?
| | Ectodermal Dysplasia | 1 | 2005 | 15 | 0.050 |
Why?
| | Transcriptome | 2 | 2022 | 1066 | 0.050 |
Why?
| | Norway | 1 | 2024 | 41 | 0.050 |
Why?
| | Connexin 43 | 1 | 2005 | 37 | 0.050 |
Why?
| | Australia | 1 | 2005 | 291 | 0.050 |
Why?
| | Social Isolation | 1 | 2005 | 73 | 0.050 |
Why?
| | Connexins | 1 | 2005 | 54 | 0.050 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2357 | 0.050 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 17 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2024 | 48 | 0.050 |
Why?
| | Mastectomy | 1 | 2025 | 188 | 0.050 |
Why?
| | Propensity Score | 1 | 2026 | 370 | 0.050 |
Why?
| | Ureteroscopy | 1 | 2022 | 15 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 295 | 0.050 |
Why?
| | Intubation, Intratracheal | 1 | 2026 | 328 | 0.050 |
Why?
| | Mammaplasty | 1 | 2025 | 148 | 0.050 |
Why?
| | Social Behavior | 2 | 2019 | 279 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 123 | 0.050 |
Why?
| | Pruritus | 1 | 2022 | 60 | 0.050 |
Why?
| | Paralysis | 1 | 2022 | 69 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2024 | 259 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2025 | 594 | 0.040 |
Why?
| | Upper Extremity | 1 | 2022 | 114 | 0.040 |
Why?
| | Hand | 1 | 2022 | 156 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2026 | 1037 | 0.040 |
Why?
| | Gene Expression | 1 | 2006 | 1461 | 0.040 |
Why?
| | Infant | 3 | 2020 | 10093 | 0.040 |
Why?
| | Tibia | 1 | 2022 | 177 | 0.040 |
Why?
| | Brain | 3 | 2023 | 2981 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 380 | 0.040 |
Why?
| | Animals | 6 | 2019 | 38030 | 0.040 |
Why?
| | Bone Density | 1 | 2024 | 492 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 4082 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 964 | 0.040 |
Why?
| | Social Sciences | 1 | 2019 | 8 | 0.040 |
Why?
| | Nebraska | 1 | 2019 | 21 | 0.040 |
Why?
| | Arkansas | 1 | 2019 | 23 | 0.040 |
Why?
| | Iowa | 1 | 2019 | 31 | 0.040 |
Why?
| | Receptors, Thrombopoietin | 1 | 2019 | 6 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1878 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2218 | 0.040 |
Why?
| | Maryland | 1 | 2019 | 67 | 0.040 |
Why?
| | Wisconsin | 1 | 2019 | 102 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 31 | 0.040 |
Why?
| | New York | 1 | 2019 | 127 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 38 | 0.040 |
Why?
| | Infrared Rays | 1 | 2018 | 23 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2019 | 85 | 0.040 |
Why?
| | Macaca fascicularis | 1 | 2018 | 70 | 0.040 |
Why?
| | Biometry | 1 | 2018 | 66 | 0.030 |
Why?
| | Morbidity | 1 | 2019 | 317 | 0.030 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 62 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 54 | 0.030 |
Why?
| | Age of Onset | 1 | 2020 | 557 | 0.030 |
Why?
| | Laryngeal Muscles | 1 | 2018 | 10 | 0.030 |
Why?
| | Voice Quality | 1 | 2018 | 23 | 0.030 |
Why?
| | Cefotaxime | 1 | 2017 | 3 | 0.030 |
Why?
| | Counseling | 1 | 2021 | 403 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 295 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 395 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 379 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1720 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 140 | 0.030 |
Why?
| | Hospitals | 1 | 2022 | 730 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 511 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2024 | 640 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1033 | 0.030 |
Why?
| | Peer Group | 1 | 2019 | 250 | 0.030 |
Why?
| | Contactins | 1 | 2016 | 2 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 1070 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 857 | 0.030 |
Why?
| | Saccades | 1 | 2016 | 45 | 0.030 |
Why?
| | Linear Models | 2 | 2012 | 847 | 0.030 |
Why?
| | Reaction Time | 1 | 2018 | 434 | 0.030 |
Why?
| | Mice | 3 | 2019 | 18266 | 0.030 |
Why?
| | Mothers | 1 | 2022 | 771 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 502 | 0.030 |
Why?
| | Alcohol Abstinence | 1 | 2015 | 13 | 0.030 |
Why?
| | Cell Survival | 1 | 2019 | 1102 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1372 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5875 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 377 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1418 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2016 | 203 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1531 | 0.030 |
Why?
| | Finland | 1 | 2014 | 72 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 295 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2112 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 115 | 0.030 |
Why?
| | Genetic Phenomena | 1 | 2013 | 7 | 0.030 |
Why?
| | Synapses | 1 | 2017 | 447 | 0.020 |
Why?
| | Electroencephalography | 1 | 2016 | 570 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 66 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 63 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2015 | 159 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2101 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 368 | 0.020 |
Why?
| | Risk-Taking | 1 | 2015 | 321 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 110 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3121 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3321 | 0.020 |
Why?
| | Parathyroidectomy | 1 | 2011 | 9 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1758 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4112 | 0.020 |
Why?
| | Chromatin | 1 | 2015 | 557 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 45 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3538 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2011 | 96 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3678 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4331 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1122 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 86 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4588 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1935 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 249 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 278 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4329 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2022 | 2962 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7079 | 0.020 |
Why?
| | Trachea | 1 | 2011 | 253 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4119 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1136 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1062 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4565 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 1979 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2011 | 641 | 0.020 |
Why?
| | Connexin 26 | 1 | 2005 | 9 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 73 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2005 | 124 | 0.010 |
Why?
| | Data Collection | 1 | 2008 | 647 | 0.010 |
Why?
| | Motor Cortex | 1 | 2005 | 64 | 0.010 |
Why?
| | Functional Laterality | 1 | 2005 | 240 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 409 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2008 | 926 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2005 | 325 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1030 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5234 | 0.010 |
Why?
| | Pain | 1 | 2005 | 787 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3917 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|